References
- Mellinger GD, Baiter MB, Uhlenhuth EH. Insomnia and its treatment: prevalence and correlates. Arch Gen Psychiatry 1985; 42(3): 225–32
- Rosekind MR. The epidemiology and occurrence of insomnia. J Clin Psychiatry 1992; 53(Suppl): 4–6
- Monane M. Insomnia in the elderly. J Clin Psychiatry 1992; 53(Suppl): 23–8
- 'Williams RL, Karacan I, Moore CA, et al. Sleep disorders. In: Kaplan HI, Sadock B, Cancro R, et al, eds. Comprehensive textbook of psychiatry. Baltimore: Williams & Wilkins, 1995; 1373–1408
- Kaplan HI, Sadock B. Normal sleep and sleep disorders. In: Kaplan HI, Sadock BJ, Grebb JA, eds. Synopsis of psychiatry: behavioral sciences clinical psychiatry. 7th ed. Baltimore: Williams & Wilkins, 1994; 699–716
- Grunstein RR. Sleep-related breathing disorders: nasal continuous positive airway pressure treatment for obstructive sleep apnea. Thorax 1995; 50(10): 1106–13
- Nino-Murcia G. Diagnosis and treatment of insomnia and risks associated with lack of treatment. J Clin Psychiatry 1992; 53(Suppl): 43–7
- Johnson LC, Chernik DA. Sedative-hypnotics and human performance. Psycho-pharmacology (Berl) 1982; 76(2): 101–13
- Dement WC. Objective measurements of daytime sleepiness and performance comparing quazepam with flurazepam in two adult populations using the Multiple Sleep Latency Test. J Clin Psychiatry 1991; 52(Suppl): 31–7
- Kaplan HI, Sadock B. Biological therapies. In: Kaplan et al, 5 p 913
- Ray WA, Griffin MR, Schaffner W, et al. Psychotropic drug use and the risk of hip fracture. N Engl J Med 1987; 316(7): 363–9
- Kramer M, Schoen LS. Problems in the use of long-acting hypnotics in older patients. J Clin Psychiatry 1984; 45(4): 176–7
- Weingartner HJ, Eckardt MJ, Hommer DW, et al. Specificity of memory impairments with triazolam use. (Letter) Lancet 1991; 338(8771): 883–4
- Greenblatt DJ. Pharmacology of benzodiazepine hypnotics. J Clin Psychiatry 1992; 53(Suppl): 7–13
- Greenblatt DJ, Harmatz JS, Shapiro L, et al. Sensitivity to triazolam in the elderly. N Engl J Med 1991; 324(24): 1691–8
- Kales A, Bixler EO, Vela-Bueno A, et al. Comparison of short and long half-life benzodiazepine hypnotics: triazolam and quazepam. Clin Pharmacol Ther 1986; 40(4): 378–86
- Roehrs T, Vogel G, Roth T. Rebound insomnia: its determinants and significance. Am J Med 1990; 88(3A): 39–42S
- Roehrs TA, Zorick FJ, Wittig RM, et al. Dose determinants of rebound insomnia. Br J Clin Pharmacol 1986; 22(2): 143–7
- Greenblatt DJ, Harmatz JS, Zinny MA, et al. Effect of gradual withdrawal on the rebound sleep disorder after discontinuation of triazolam. N Engl J Med 1987; 317(12): 722–8
- Langtry HD, Benfield P. Zolpidem: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs 1990; 40(2): 291–313
- Fairweather DB, Kerr JS, Hindmarch I. The effects of acute and repeated doses of zolpidem on subjective sleep, psychomotor performance and cognirive function in elderly volunteers. Eur J Clin Pharmacol 1992; 43(6): 597–601
- Brunner DP, Dijk DJ, Munch M, et al. Effect of Zolpidem on sleep and sleep EEG spectra in healthy young men. Psychopharmacology (Berl) 1991; 104(1): 1–5
- Scharf MB, Mayleben DW, Kaffeman M, et al. Dose response effects of zolpidem in normal geriatric subjects. J Clin Psychiatry 1991; 52(2): 77–83
- Ware JC, Pittard JT. Increased deep sleep after trazodone use: a double-blind placebo-controlled study in healthy young adults. J Clin Psychiatry 1990; 51(Suppl): 18–22
- Shader RI, Kennedy JS. Psychiatric disorders of late life, biological treatments. In: Kaplan HI, Sandock BJ, eds. Comprehensive textbook of psychiatry. 5th ed. Baltimore: Williams & Wilkins, 1989; 2037–53
- Tzischinsky O, Lavie P. Melatonin possesses time-dependent hypnotic effects. Sleep 1994; 17(7): 638–45
- Mendels J. Criteria for selection of appropriate benzodiazepine hypnotic therapy. J Clin Psychiatry 1991; 52(Suppl): 42–6